SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-394322
Filing Date
2014-11-03
Accepted
2014-11-03 17:28:18
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d802324d10q.htm 10-Q 317095
2 EX-10.1 d802324dex101.htm EX-10.1 9265
3 EX-31.1 d802324dex311.htm EX-31.1 5992
4 EX-31.2 d802324dex312.htm EX-31.2 6052
5 EX-32 d802324dex32.htm EX-32 4561
12 GRAPHIC g802324logo.jpg GRAPHIC 15008
  Complete submission text file 0001193125-14-394322.txt   3194284

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itci-20140930.xml EX-101.INS 443198
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20140930.xsd EX-101.SCH 29724
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20140930_cal.xml EX-101.CAL 39405
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20140930_def.xml EX-101.DEF 90639
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20140930_lab.xml EX-101.LAB 265625
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20140930_pre.xml EX-101.PRE 178983
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 141190441
SIC: 2834 Pharmaceutical Preparations